Withdrawals due to adverse events · older adults with primary hypertension
Higher BP target (< 150‐160/95‐105 mmHg) showed no clear difference in withdrawals due to adverse effects compared with lower BP target (< 140/90 mmHg) (low certainty).
1 finding from 1 review
Intervention not reported
mg/day LDL cholesterol · participants with normal or abnormal lipid profiles
The intervention showed no clear difference in mg/day LDL cholesterol (high certainty).
1 finding from 1 review
Intervention not reported
mg/day LDL cholesterol · participants with normal or abnormal lipid profiles
The intervention showed no clear difference in mg/day LDL cholesterol (moderate certainty).
1 finding from 1 review
Intervention not reported
mg/day LDL cholesterol · participants with normal or abnormal lipid profiles
The intervention showed no clear difference in mg/day LDL cholesterol (moderate certainty).
1 finding from 1 review
Intervention not reported
mg/day LDL cholesterol · participants with normal or abnormal lipid profiles
The intervention showed no clear difference in mg/day LDL cholesterol (high certainty).
1 finding from 1 review
Intervention not reported
Pravastatin 10 to 80 mg/day (6 to 156 weeks) · participants with normal or abnormal lipid profiles
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
WDAEs · participants with normal or abnormal lipid profiles
It is very uncertain whether the intervention changes WDAEs (very low certainty).
1 finding from 1 review
Variation in the decrease in 24‐hour ambulatory hourly SBP (at 3 to 12 weeks) · Men and non‐pregnant women ≥ 18 years old with essential hypertension
1 finding from 1 review
no estimate extracted
121 participants
Very low
Variation in the decrease in 24‐hour ambulatory hourly DBP (at 3 to 12 weeks) · Men and non‐pregnant women ≥ 18 years old with essential hypertension
1 finding from 1 review
no estimate extracted
121 participants
Very low
Variation in the decrease in 24‐hour ambulatory hourly HR (at 3 to 12 weeks) · Men and non‐pregnant women ≥ 18 years old with essential hypertension
1 finding from 1 review
no estimate extracted
71 participants
Very low
Intervention not reported
Cerivastatin dose · participants with normal or abnormal lipid profiles
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
0.05 mg/d · participants with normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
0.1 mg/d · participants with normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
0.2 mg/d · participants with normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
0.3 mg/d · participants with normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
0.4 mg/d · participants with normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
0.8 mg/d · participants with normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
CI: confidence interval · participants with normal or abnormal lipid profiles
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
aMean baseline values. · participants with normal or abnormal lipid profiles
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
Cerivastatin dose · participants with normal or abnormal lipid profiles
The review found no eligible studies for this question.
1 finding from 1 review